Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs Moderna, Inc. — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while Moderna, Inc. trades at $196.71 (market cap $78.44B). The key difference: Canadian Pacific Kansas City Limited Common Shares and Moderna, Inc. are close in size by market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.91% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| CP | MRNA | |
|---|---|---|
Market Cap | $73.71B | $78.44B |
Volume | 2,143,178 | 14,597,511 |
Sector | Industrials | Health |
52-Week High | $96.69 | $203.46 |
52-Week Low | $68.88 | $22.36 |
Enterprise Value | $91.14B | $74.59B |
Dividend Yield | 0.91% | — |
Typical Hold Time | — | 59 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $197.00, up 5.09% today, with a bullish technical signal supported by moving averages. Recent inclusion in the Nasdaq-100 index has driven positive momentum, though the stock faces valuation concerns after a 500% rally in 2026. Financially, revenue has declined from $18.9B in 2022 to $1.92B in 2025, with net losses widening to -$2.82B. Earnings have consistently beaten expectations, but profitability metrics remain negative.
Outlook: Near-term upside may be capped by high valuations and profit-taking pressure, but long-term growth potential exists in the oncology pipeline. Key risks include sustained revenue declines, competitive threats, and reliance on pipeline success. Analysts are mixed, with a consensus price target of $115.70 suggesting caution despite bullish technicals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
